Skip to main content
. 2016 May 9;7(27):41217–41232. doi: 10.18632/oncotarget.9251

Figure 5. GAS6 activates mTOR signaling through Mer.

Figure 5

(A) Activation of mTOR signaling with GAS6 treatment in prostate cancer with TAM (Tyro3, Axl, Mer) receptors knocked down. (B) Activation of mTOR signaling with GAS6 treatment in prostate cancer in the presence/absence of Mer inhibitor (UNC1062).